GRAM POSITIVE BACTERIAL INFECTIONS MARKET ANALYSIS
Gram Positive Bacterial Infections Market Regional Analysis
On the basis of region, the global gram positive bacterial infections market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
North America is expected to hold dominant position in the gram positive bacterial infections market, owing to increasing launch of antibacterial drugs acting against gram positive bacteria. For instance, in January 2018, Melinta Therapeutics, Inc. launched its new drug, Baxdela antibiotic containing Delafloxacin, for the treatment of acute bacterial skin and skin structure infections (ABSSSI).
Europe is also expected to witness significant growth in the gram positive bacterial infections market, owing to increasing collaboration and acquisition activities adopted by market players. For instance, in March 2019, Evotec AG (headquartered in Germany) collaborated with the Global Antibiotic Research and Development Partnership (GARDP). This collaboration focuses on accelerating the development of novel antibiotic treatments.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
